SCHEMBL1632063

SCHEMBL1632063

c1ccc2c(c1)Cc1c-2cccc1-c1cccc2c1CCCN2

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 1/20 0.42
▸ BCHE P06276 1/20 0.41
▸ NUDT1 P36639 8/20 0.40
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PGR P06401 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA4 P22748 1/20 0.36
▸ CA6 P23280 1/20 0.36
▸ MAP3K9 P80192 1/20 0.36
▸ MAP3K11 Q16584 1/20 0.36
▸ GRIA1 P42261 1/20 0.36
▸ GRIA2 P42262 1/20 0.36
▸ GRIA3 P42263 1/20 0.36
▸ GRIA4 P48058 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29907266 0.83 PGR (0.42) PNMTBCHENUDT1NPC1RAB9A
Fluorene SCHEMBL15052014 0.80 ALOX15 (0.46) BCHENPC1RAB9ADRD2CA1
SCHEMBL4366358 0.79 PARP1 (0.42) BCHENUDT1KDM1AHTR1ADRD2
SCHEMBL14785203 0.78 PARP10 (0.51) BCHENUDT1NPC1HTR1ADRD2
SCHEMBL524602 0.76 PNMT (0.63) PNMTBCHENPC1RAB9APGR
SCHEMBL30103334 0.76 PNMT (0.63) PNMTBCHENPC1RAB9APGR
SCHEMBL4213135 0.76 KDM1A (0.47) BCHENUDT1KDM1AHTR1ADRD2
SCHEMBL18322825 0.75 PDPK1 (0.46) BCHENUDT1CA1CA2
SCHEMBL4206469 0.75 BCHE (0.39) BCHENUDT1KDM1AHTR1ADRD2
SCHEMBL20539302 0.74 NOTUM (0.47) BCHEKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120836-B2 Method for preparing transition metal complexes, transition metal complexes prepared using the method, catalyst composition containing the complexes LG CHEM, LTD. (KR) 2015-09-01 — — US disclosed
EP-1999165-B9 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG CHEMICAL LTD (KR) 2013-09-11 — — EP disclosed
EP-1999165-B1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG CHEMICAL LTD (KR) 2013-04-24 — — EP disclosed
US-8048973-B2 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition LG CHEM, LTD. (KR) 2011-11-01 — — US disclosed
US-8039671-B2 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition LG CHEM, LTD. (KR) 2011-10-18 — — US disclosed
US-20110177935-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES LG CHEM, LTD. (KR) 2011-07-21 — — US disclosed
US-20110172451-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES LG CHEM, LTD. (KR) 2011-07-14 — — US disclosed
US-20110160413-A1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG CHEM, LTD. (KR) 2011-06-30 — — US disclosed
US-20110152529-A1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG CHEM, LTD. (KR) 2011-06-23 — — US disclosed
US-7932207-B2 Method for preparing transition metal complexes, transition metal complexes prepared using the method, catalyst composition containing the complexes LG CHEM, LTD. (KR) 2011-04-26 — — US disclosed
US-7928256-B2 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition LG CHEM, LTD. (KR) 2011-04-19 — — US disclosed
US-20100062927-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARE USING THE METHOD, CATALYTS COMPOSITION CONTAINING THE COMPLEXES LG CHEM, LTD. (KR) 2010-03-11 — — US disclosed
EP-1999165-A1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG Chem, Ltd. (KR) 2008-12-10 — — EP disclosed
WO-2008084931-A9 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYSTS COMPOSITION CONTAINING THE COMPLEXES LG CHEMICAL LTD (KR) 2008-11-13 — — WO disclosed
WO-2008084931-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYSTS COMPOSITION CONTAINING THE COMPLEXES LG CHEM, LTD. (KR) 2008-07-17 — — WO disclosed
WO-2007111423-A1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION LG CHEM, LTD. (KR) 2007-10-04 — — WO disclosed
US-20070225158-A1 Transition Metal Complex, Catalyst Composition Including the Same and Olefin Polymer Using Catalyst Composition LG CHEM, LTD. (KR) 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225158-A1 Transition Metal Complex, Catalyst Composition Including the Same and Olefin Polymer Using Catalyst Composition OSTC, MACO1, PORCN PNMT 1259/4885BCHE 4362/4885NUDT1 3897/4885
US-20110172451-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES PPOX, MACO1, MSMO1 PNMT 228/4885BCHE 3982/4885NUDT1 398/4885
US-20110152529-A1 TRANSITION METAL COMPLEX, CATALYST COMPOSITION INCLUDING THE SAME AND OLEFIN POLYMER USING CATALYST COMPOSITION OSTC, MACO1, PORCN PNMT 1259/4885BCHE 4362/4885NUDT1 3897/4885
US-20100062927-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARE USING THE METHOD, CATALYTS COMPOSITION CONTAINING THE COMPLEXES PPOX, CPNE4, CYCS PNMT 826/4885BCHE 3223/4885NUDT1 2905/4885
US-20110177935-A1 METHOD FOR PREPARING TRANSITION METAL COMPLEXES, TRANSITION METAL COMPLEXES PREPARED USING THE METHOD, CATALYST COMPOSITION CONTAINING THE COMPLEXES PPOX, C9, C5 PNMT 802/4885BCHE 4590/4885NUDT1 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback